This crucial role of SETD2 in lipid metabolism is further validified with in vivo intervention that tumor symptom caused by Setd2 knockout is mitigated by myriocin, a selective inhibitor for sphingomyelin biosynthesis. Here, SETD2 is linked to neoplasm.